MedPath

An Observational Study of Herceptin SC Safety in Breast Cancer

Completed
Conditions
Breast Cancer
Registration Number
NCT02305628
Lead Sponsor
Hoffmann-La Roche
Brief Summary

This is a phase IV, prospective, multicenter, observational study (regulatory post-marketing surveillance) in approximately 600 patients who are to receive Herceptin SC (trastuzumab, subcutaneous administration) per approved local labeling. Patients will be under observation according to standard of care in Korea.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
600
Inclusion Criteria
  • All patients administered Herceptin SC for the locally approved indications
Read More
Exclusion Criteria

N/A

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety (composite outcome measure): Incidence of adverse events (AEs), serious adverse events (SAEs), adverse events of special interest, pregnancies, adverse drug reactions (ADRs); unexpected ADRs; expected ADRsUp to 6 years
Secondary Outcome Measures
NameTimeMethod
Efficacy: Overall response per Response Evaluation Criteria in Solid Tumors (RECIST)Up to 6 years
Efficacy: Pathological Complete Response (pCR) in neoadjuvant early breast cancer (EBC)Up to 6 years

Trial Locations

Locations (23)

Ulsan University Hosiptal

🇰🇷

Ulsan, Korea, Republic of

Hallym University Sacred Heart Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

Gachon University Gil Medical Center

🇰🇷

Incheon, Korea, Republic of

Ajou University Medical Center

🇰🇷

Gyeonggi-do, Korea, Republic of

Chonnam National University Hwasun Hospital

🇰🇷

Jeollanam-do, Korea, Republic of

Wonkwang University School of Medicine & Hospital

🇰🇷

Jeonlabuk-do, Korea, Republic of

ChungAng University Hospital

🇰🇷

Seoul, Korea, Republic of

Severance Hospital, Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

Inje University, Sanggye-Paik Hospital

🇰🇷

Seoul, Korea, Republic of

Cheil General Hospital & Women's Healthcare Center

🇰🇷

Seoul, Korea, Republic of

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Gyeongsang National University Hospital

🇰🇷

Gyeongsangnam-do, Korea, Republic of

Pusan National University Yangsan Hospital

🇰🇷

Gyeongsangnam-do, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Korea Cancer Hospital of Korea Institute of Radiological and Medical Sciences

🇰🇷

Seoul, Korea, Republic of

Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Miz Medi Hospital

🇰🇷

Seoul, Korea, Republic of

Myongji Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

Kosin University Gospel Hospital

🇰🇷

Busan, Korea, Republic of

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Borame Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath